Patents by Inventor Torsten Falk

Torsten Falk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR TREATING MOTOR DISORDERS
    Publication number: 20230000797
    Abstract: This invention provides methods utilizing ketamine for the treatment of motor disorders and/or side effects associated with certain medications used in the treatment of motor disorders. For example, in some embodiments, methods are provided for treating side effects associated with the administration of levodopa to a subject having Parkinson's disease, by administering a dose of ketamine or a pharmaceutically acceptable salt thereof. In particular, the invention provides methods for reducing dyskinesia associated with motor disorder (e.g.
    Type: Application
    Filed: August 29, 2022
    Publication date: January 5, 2023
    Inventors: Scott Sherman, Torsten Falk, Miguel Estevez
  • GLYCOPEPTIDE ANALOGS OF SECRETIN FAMILY PEPTIDES
    Publication number: 20220380431
    Abstract: Glycopeptide analogs of secretin family peptides, including PACAP and VIP, are described herein. These glycopeptides analogs can have neuroprotective properties and enhanced ability to cross the blood brain barrier (BBB) and/or enhanced stability. These glycosylated peptides can be used as drugs for treatment of CNS disorders, such as Parkinson's disease.
    Type: Application
    Filed: August 9, 2018
    Publication date: December 1, 2022
    Inventors: Robin L. Polt, Christopher Apostol, Michael L. Heien, Chenxi Liu, John M. Streicher, Lajos Z. Szabo, Torsten Falk
  • Compositions and methods for treating motor disorders
    Patent number: 11426366
    Abstract: This invention provides methods utilizing ketamine for the treatment of motor disorders and/or side effects associated with certain medications used in the treatment of motor disorders. For example, in some embodiments, methods are provided for treating side effects associated with the administration of levodopa to a subject having Parkinson's disease, by administering a dose of ketamine or a pharmaceutically acceptable salt thereof. In particular, the invention provides methods for reducing dyskinesia associated with motor disorder (e.g., Parkinson's disease) treatments, and effective doses of ketamine or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: May 12, 2016
    Date of Patent: August 30, 2022
    Assignee: ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSSITY OF ARIZONA
    Inventors: Scott Sherman, Torsten Falk, Miguel Estevez
  • COMPOSITIONS AND METHODS FOR TREATING MOTOR DISORDERS
    Publication number: 20190060254
    Abstract: This invention provides methods utilizing ketamine for the treatment of motor disorders and/or side effects associated with certain medications used in the treatment of motor disorders. For example, in some embodiments, methods are provided for treating side effects associated with the administration of levodopa to a subject having Parkinson's disease, by administering a dose of ketamine or a pharmaceutically acceptable salt thereof. In particular, the invention provides methods for reducing dyskinesia associated with motor disorder (e.g., Parkinson's disease) treatments, and effective doses of ketamine or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: May 12, 2016
    Publication date: February 28, 2019
    Inventors: Scott Sherman, Torsten Falk, Miguel Estevez